Titles and Roles
- Acting Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Research Program
- Discovery and Developmental Therapeutics
Kristie A. Blum, MD, is Acting Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. A board certified hematologist, Dr. Blum has extensive experience in the clinical development of novel therapeutics for patients with aggressive B-cell non-Hodgkin's lymphoma and Hodgkin's lymphoma. Prior to joining Emory in 2017, Dr. Blum was Professor in the Divison of Hematology in the Department of Internal Medicine at The Ohio State University - James Cancer Hospital and Solove Research Institute where she was also the Director of the Lymphoma Clinical Research Program.
Dr. Blum is co-chair of the NCI Lymphoma Steering Committee. She is also a member of the Lymphoma Research Foundation Scientific Advisory Board, the AllianceCo-Operative Group Lymphoma Committee, the American Society of Hematology Clinical Research Mentoring Program, and the National Comprehensive Cancer Network Hodgkin's Lymphoma Panel. She developed and chaired the first two Lymphoma Research Foundation Clinical Research Mentoring Programs from 2013-2015.
Dr. Blum received her medical degree from the University of Miami School of Medicine in Miami, Florida. She completed her residency in internal medicine at the University of Virginia in Charlottesville, Virginia. She also completed a fellowship in hematology/oncology at Washington University in St. Louis, Missouri and Vanderbilt University in Nashville, Tennessee.
Dr. Blum's research is focused on developing novel targeted therapies for patients with relapsed or refractory Hodgkin's lymphoma and aggressive B-cell non-Hodgkin's lymphoma, including mantle cell lymphoma, diffuse large B-cell lymphoma and transformed lymphomas. Her research is also focused on treatment of adolescent and young adult patients with lymphomas.
Publications Publication Date